Our current systems biology analysis of human melanoma was conducted in an unbiased fashion to fully interrogate dysfunctional CD8+PD-1+TIM-3+ TIL (sorted) transcriptomic profiles, allowing for the identification of novel and unexpected signaling pathways that may reveal enhancement targets in more recent immune checkpoint blockade therapies. The gene discussed is PDCD1; the disease is melanoma.